Recombinant Monoclonal Anti-PD-L1 Antibody, Rabbit (5D3), Ready-To-Use

用户评价
货号-规格
价格
Qty.
CAA-B001-7.5ml
¥10015.00
合计0件 产品金额¥ 0

产品详情

  • 产品概述(Product Overview)

    PD-L1 is an informative immunotherapy biomarker: Aberrant expression of PD-L1 on tumor and immune cells in the tumor microenvironment impedes anti-tumor immunity, allowing tumors to grow and metastasize. The PD-L1 IHC Antibody (5D3) is a ready-to-use antibody working solution to detect PD-L1 across tumors to identify patients eligible for multiple targeted therapies. Product are manufactured in a dedicated GMP facility and are compliant with our ISO 13485 quality management system.

  • 产品参数(Product Specifications)

    Analyte
    PD-L1
    Format
    7.5ml
    Reactivity
    Human
    Species
    Rabbit
    Regulatory Status
    RUO
    Applicable Platform
    LEICA BOND III、DAKO link 48
  • 组分(Materials Provided)

    Recombinant Monoclonal Anti-PD-L1 Antibody, Rabbit (5D3)

  • 应用说明(Application)

    The kit is developed for use in the PD-L1 protein in the formalin-fixed, paraffin-embedded tissue. It is indicated as an aid in the assessment of PD-L1 expression in human tissues.

  • 状态(State)

    Liquid

  • 存储(Storage)

    Stored at 2°C to 8°C. The shelf life is 30 days from the date of opening.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐产品

数据展示

  • 质控样本(Control Sample)

     PD-L1 CONTROL SAMPLE

    Use ACRO PD-L1 5D3 kit to stain human tonsil tissue, positive cell membrane specific positive staining (staining intensity ≥ 1), no non-specific staining (staining intensity < 1) , no background staining (staining intensity < 1 ).

肿瘤样本(Cancer Sample)
  • 一致性(Consistency)

    ACRO PD-L1 5D3 and DAKO PD-L1 22C3 conformance verification, with a high consistency rate (>95%).

     PD-L1 CONSISTENCY
     PD-L1 CONSISTENCY
     PD-L1 CONSISTENCY

    Use ACRO PD-L1 5D3 to stain non-small cell lung cancer, esophageal squamous cell carcinoma and liver cancer, respectively. The results showed that the staining effect was highly consistent.

  • 扩展性(Extensibility)

    ACRO PD-L1 5D3 expandable test: non-small cell lung cancer, esophageal carcinoma, gastric cancer, colorectal cancer and liver cancer.

     PD-L1 EXTENSIBILITY
     PD-L1 EXTENSIBILITY
     PD-L1 EXTENSIBILITY

    Use ACRO PD-L1 5D3 kit to stain NSCLC, esophageal carcinoma, gastric cancer, colorectal cancer, liver cancer tissue samples respectively.

  • 适用性(Applicability)

    ACRO PD-L1 5D3 can be available on the LEICA BOND III platform.

     PD-L1 APPLICABILITY
     PD-L1 APPLICABILITY
     PD-L1 APPLICABILITY

    Use ACRO PD-L1 5D3 kit to stain NSCLC tissue samples at Leica BOND-III.

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    Programmed death-ligand 1

  • 中文全称:

    程序性死亡配体1

  • 种类:

  • 上市药物数量:

    11 详情

  • 临床药物数量:

    152 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • 产品基础信息
  • 产品详情
  • 推荐产品
  • 数据展示
  • 用户评价